Five ‘Big Idea’ Biotech Trends To Watch In 2017

Five ‘Big Idea’ Biotech Trends To Watch In 2017

(Photo credit should read REMY GABALDA/AFP/Getty Images)

Different types of stories cross my radar as a biotech journalist every day.

There are partnerships between established drugmakers that need new products and the little aspiring companies that need cash to develop their thing. Stories about clinical trial results that move markets. Regulatory actions that make or break companies and investors.

But for me, there’s something especially fun about talking with scientific entrepreneurs who raised their first big wad of investment cash. They’re latching onto some kernel of insight from a discovery. Or maybe they have a vision for stitching together a set of technologies. Either way, they are venturing into a great unknown to see if they can make a big step ahead in medicine. They often have insights that put them years ahead of the lumbering drug giants.

 

Source: https://www.forbes.com/sites/luketimmerman/2016/12/27/five-big-idea-biotech-trends-to-watch-in-2017/2/#6368d858f501

Related Post

Spotlight – KRS: A cut away from release in ...
views 3979
Spotlight KRS: A cut away from release in exosomes  View ORCID Profile  Catherine Rabouille DOI: 10.1083/jcb.2...
More New Cancer Drugs Mean Higher Costs But Also L...
views 528
More New Cancer Drugs Mean Higher Costs But Also Longer Lives by MAGGIE FOX Spending on cancer treatments has spiked past the $1...
백신 개발·DNA 해독… 전염병 막을 ‘국제연합군’ 뭉쳤다...
views 302
백신 개발·DNA 해독… 전염병 막을 '국제연합군' 뭉쳤다 박건형 기자 황승식 서울대 보건대학원 교수 입력 : 2017.06.03 03:02 판데믹에 맞서는 인류 WHO·美·유럽 중심으로 에볼라 백신 개발 성공 빌 게이...
ARS research comes to Gordon Research Conference
views 216
Biocon의 주력 타겟군인 ARS (aminoacyl-tRNA synthetase)들과 translation, disease, cure들의 주제가 Gordon Research Conference 주제로 선정이 되어 2015년부터 2년 간격으로 개최가 될 예정입니다.현...

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

©2010-2018 Medicinal Bioconvergence Research Center. All rights reserved.

Log in with your credentials

Forgot your details?

Skip to toolbar